Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential.
Tuck JR, Dunlap LE, Khatib YA, Hatzipantelis CJ, Weiser Novak S, Rahn RM, Davis AR, Mosswood A, Vernier AMM, Fenton EM, Aarrestad IK, Tombari RJ, Carter SJ, Deane Z, Wang Y, Sheridan A, Gonzalez MA, Avanes AA, Powell NA, Chytil M, Engel S, Fettinger JC, Jenkins AR, Carlezon WA Jr, Nord AS, Kangas BD, Rasmussen K, Liston C, Manor U, Olson DE.
Tuck JR, et al. Among authors: kangas bd.
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2416106122. doi: 10.1073/pnas.2416106122. Epub 2025 Apr 14.
Proc Natl Acad Sci U S A. 2025.
PMID: 40228113
Free PMC article.